Genotyping of Mycobacterium leprae for understanding the distribution and transmission of leprosy in endemic provinces of China
Santosh Chokkakula(Chungbuk National University), Hongsheng Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Varalakshmi Vissa(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanfei Kuang(Hunan Provincial Center for Disease Control and Prevention), Ying Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Naveenchandra Suryadevara(Vanderbilt University), Limei Shen(Guizhou Provincial Science and Technology Department), De Wang(Guizhou Provincial Science and Technology Department), Li Xiong, Tiejun Shui(Yunnan Province Science and Technology Department), Haiqin Jiang(Nanjing University), Meiwen Yua(Chinese Academy of Medical Sciences & Peking Union Medical College), Le Wang(National Center for AIDS/STD Control and Prevention,China CDC), Huan Chen(Nanjing Agricultural University), Bin Li(Hunan Provincial Center for Disease Control and Prevention), Jun He(Yunnan Province Science and Technology Department), Yanqing Chen(Nanfang Hospital), Jie Liu(Guizhou Provincial Science and Technology Department), Wenyue Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Liangbin Yan(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Yang(Yunnan Province Science and Technology Department), Hao Wang(Chinese PLA General Hospital), Balaji Pathakumari(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinlan Li(Fujian Medical University), Lemuel Shui Lun Tsang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 14
Related Papers
Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China
|CHEST Journal|2014|270
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
|Antiviral Research|2022|82
Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy
|Microorganisms|2023|77
SARS-CoV-2 drug resistance and therapeutic approaches
|Heliyon|2025|44